Explore a tangible roadmap towards achieving a truly world-class health care system in the Middle East and North Africa

www.hcmena.economist.com

Gold Sponsors Exhibitor sponsor Official PR Agency

Research Based Pharmaceutical Companies Committee in Saudi

PhRMAGPharmaceutical Research &Manufacturers Association Gulf

HEALTH CARE MIDDLE EAST AND NORTH AFRICAInnovation powering health-care delivery

October 13th 2015, Madinat Jumeirah, Mina A’Salam, Dubai

Join the conversation@EconomistEvents#hcmena

Knowledge partnerSilver sponsor

www.hcmena.economist.com

ABOUT THE SUMMITHow can the Middle East and North Africa deliver a truly world-class health-care system?The MENA region has faced a surge in demand for health care services in recent years. Shifting socio-economic factors such as increased income and better access to modern amenities have led to widespread lifestyle changes, fuelling a rise in lifestyle-related illnesses such as cancer, obesity, diabetes and heart disease.

According to the World Health Organisation (WHO), non-communicable diseases will account for nearly 60% of the region’s disease burden in the next five years. The International Diabetes Federation (IDF) estimates that one in 10 adults in the Middle East region currently suffers from diabetes. It forecasts that this figure will more than double over the next twenty years, reaching 68 million, or 25% of the estimated population by 2035.

Join us as we bring together decision makers from the public and private sectors to explore how can the Middle East & North Africa deliver a truly world-class health care system:• Hear from national and international policy makers representing the World Health Organisation, Ministry of

Education Bahrain and International Diabetes Federation.

• Gain new perspectives on the future of health-care systems in the region; discuss policy, trends, tackling the talent crisis, international benchmarking and technological innovation.

• Network with influential health-care stakeholders that include government, pharmaceutical, biotech, healthcare providers, suppliers, patient groups and NGOs.

HEALTH CARE MIDDLE EAST SUMMIT 2014 STATISTICS

182 attendees

100% of our audience would recommend our event to colleagues

17

Group discounts are available for groups of 3 or more delegates.

Please email the team on emeaevents@economist.com or call +44 (0) 207 576 8118 for further details

62% of the audience were

director level or above

countries represented

Supporting organisations Supported by Supporting publications

PROGRAMME

Excellently planned and managed event. Managing Director DNA Health Corp

8.15 Registration

09.15 OPENING REMARKS FROM THE CHAIRDr Vivek Muthu, Chief Health Advisor, Economist Intelligence Unit Healthcare, United Kingdom

09.30 KEYNOTE ADDRESS: DRIVING GROWTH AND COMPETITIVENESS IN THE HEALTH CARE SECTORHE Dr Amin Al-Amiri, Assistant Undersecretary, Ministry of Health, United Arab Emirates

10.00 KEYNOTE ADDRESS: HEALTH CARE SECTOR INNOVATION: ECONOMIC DIVERSIFICATION AND ACHIEVING A KNOWLEDGE-BASED ECONOMY HE Hani Al-Hamli, Secretary General, Dubai Economic Council, United Arab Emirates

10.30 PANEL DISCUSSION: HEALTH CARE POLICY AND THE ROLE OF INDUSTRY: ALIGNING PUBLIC AND PRIVATE SECTOR OBJECTIVES TO DRIVE INNOVATION IN HEALTH CARE DELIVERYAccording to WHO statistics, the GCC has one of the highest incidences of NCDs in the world. A vast youth demographic and a rapidly ageing population, paired with vast socio-economic disparity across the region resulting in varying rates of access to health care facilities and treatments, regional governments are facing significant challenges to ensure health systems are robust, sustainable and provide quality, affordable care to all. The GCC pricing harmonisation policy, enacted throughout 2014, has been a strategic attempt to regulate pricing and improve access to medicines. However, there is debate around the efficacy of this policy many argue that price restrictions are hindering innovation and ultimately, adversely affecting patient health as well as sector growth. This session will bring together key stakeholders from government and the private sector to talk about the strategic policies guiding the future of health care in the region, identifying the main challenges to implementation, and what tangible KPIs need to be put in place to ensure a collaborative approach to foster innovation and deliver world-class health care throughout the Middle East.

Marwan Abdulaziz Executive Director, DuBiotech, United Arab Emirates Dr Petra Wilson, Chief Executive Officer, International Diabetes Federation, Belgium Dr Sameen Siddiqi, Director, Department of Health Systems Development, World Health Organization, Eastern Mediterranean Regional Office (WHO EMRO), EgyptSamir A. Khalil, PhRMA, United Arab Emirates

11.20 MORNING REFRESHMENTS AND NETWORKING BREAK

11.50 PANEL DISCUSSION: EVOLVING HEALTH CARE TRENDS: IMPROVING ACCESSIBILITY, EFFICIENCY AND EFFECTIVENESSThis session will provide a platform for discussion around evolving health care trends across the MENA region, including feedback on initiatives empowering primary care physicians and the growing scope of primary care centres. It will examine the role of community-centred care and ‘accessible cities’ outpatient facilities for more efficient, and accessible, treatment options for chronic illnesses, rehabilitative care, geriatric as well as examine the issue of patient accountability. It will also evaluate regional initiatives to improve affordability and access to care such as compulsory insurance regulations, providing feedback on how these programmes are rolling out and lessons learned from a year in review as well as a discussion around how innovation is improving efficiency and effectiveness in health care delivery.

Dr A Abyad, Chief Executive Officer, Abyad Medical Center, LebanonDr Mahiben Maruthappu, Co-founder, NHS Innovator Accelerator, United Kingdom Arjen Radder, Chief Executive Officer, Philips, Middle East & Turkey Hisham Radwan, Vice-president, Regional General Manager – MEA, Aetna International, United Arab Emirates

Tuesday October 13th 2015

12.40 INTERNATIONAL BENCHMARKING: HOW IS SINGAPORE DRIVING INNOVATION AND VALUE-GENERATION IN BIOMEDICAL R&D?Over the past twenty years, Singapore has made a concerted effort to establish itself as a global leader in biomedical R&D. This session will provide a model demonstrating the link between health care investment in R&D, skills training, manufacturing and innovation resulting in Singapore’s current position as a world-leading health care hub.

Dr Benjamin Seet, Executive Director, Biomedical Research Council, Singapore

13.15 LUNCH

14.20 TACKLING THE TALENT CRISIS: EDUCATION AND SKILLS TRAINING FOR A SUSTAINABLE HEALTH CARE SYSTEMThe Middle East is facing a severe shortage of skilled medical talent. With the major push to increase capacity in recent years leading to an ever-growing number of health care facilities, and increased demand from a growing population burdened with high rates of NCDs, the pressure is on to source qualified medical professionals. In the GCC, it is estimated that over 80% of physicians and nurses are expats. Authorities are faced with the task of encouraging MENA nationals to take roles in the burgeoning health care sector, whilst also ensuring the educational framework is in place to support further skills development. This session will explore what is being done to address the talent shortage in the health care sector and what measures need to be put in place to ensure a sustainable resource infrastructure going forward.

Cameron Mirza, Head of Projects and Strategy, Secretariat-General of the Higher Education Council, Ministry of Education, Bahrain Dr Javaid I. Sheikh, Dean, Weill Cornell Medical College, QatarDr Mussaad al-Razouki, Chief Business Development Officer, Kuwait Life Sciences Company, KuwaitDr Sulaiman al-Emran, Deputy Secretary General, Saudi Commission for Health Specialties, Saudi Arabia

15.10 PANEL DISCUSSION: TECHNOLOGICAL INNOVATION AND QUALITY OF CAREPatient safety, resource efficiency, affordability and accessibility are all key considerations when evaluating quality of care outcomes. Advancements in medical technologies and ICT mean that health care systems and providers are better able to treat and care for patients, with the added benefit of improving efficiencies and reducing costs. This session will delve into the role of innovation in how we collect, manage and analyse patient data, as well as evaluate the latest technological innovations allowing for more affordable, higher quality care in the MENA region.

•How is technology improving patient-centricity and patient outcomes?

•What role does technological innovation play in attracting private investment into the health care sector?

Dr Bern Shen, Chief Medical Officer, HealthCrowd, United Arab EmiratesGareth Sherlock, Chief Information Officer, Cleveland Clinic Abu Dhabi, United Arab EmiratesDr Helmut M. Schühsler, Chairman and Chief Executive Officer, TVM Capital Healthcare Partners, United Arab EmiratesDr Mohammad al-Redha, Director, Health Data and Information Analysis Department, Dubai Health Authority, United Arab Emirates

16.00 CLOSING KEYNOTE: THE FUTURE OF HEALTH CARE: FOCUS ON THE PATIENT EXPERIENCE Hear from this world-leader in health care on the trends and innovations that are best serving patients.

Dr David Hayes, Medical Director, Mayo Clinic Care Network and International Relations, Mayo Clinic, United States

16.30 CLOSING REMARKS AND END OF CONFERENCE

It brought stakeholders from all walks of life/business togetherDirector UNAIDS

CONFIRMED SPEAKERS INCLUDE:

MARWAN ABDULAZIZ Executive Director DuBiotech United Arab Emirates

DR SULAIMAN EL-EMRAN Deputy Secretary General Saudi Commission for Health Specialties Saudi Arabia

DR A ABYAD Chief Executive Officer Abyad Medical Center Lebanon

SAMIR A. KHALIL Executive Director, Middle East & Africa PhRMA United Arab Emirates

DR BENJAMIN SEETExecutive Director Biomedical Research Council Singapore

CAMERON MIRZA Head of Projects and Strategy Secretariat-General of the Higher Education Council, Ministry of Education Bahrain

HISHAM RADWAN, Vice-president, Regional General Manager – MEA Aetna International United Arab Emirates

DR SAMEEN SIDDIQI Director, Department of Health Systems Development World Health Organization, Eastern Mediterranean Regional Office (WHO EMRO) Egypt

DR DAVID HAYES Medical Director Mayo Clinic Care Network and International Relations Mayo Clinic United States

DR MOHAMMAD AL-REDHA Director, Health Data and Information Analysis Department Dubai Health Authority United Arab Emirates

DR JAVAID I. SHEIKH Dean Weill Cornell Medical College Qatar

BERN SHEN Chief Medical Officer HealthCrowd United Arab Emirates

Sponsorship opportunities are available. Please contact Kay Westmoreland on +971 4433 4208 or email kaywestmoreland@economist.com.

DR PETRA WILSON Chief Executive Officer International Diabetes Federation Belgium

GARETH SHERLOCK Chief Information Officer Cleveland Clinic Abu Dhabi United Arab Emirates

DR VIVEK MUTHU Chief Health Advisor Economist Intelligence Unit Healthcare United Kingdom

2014 ATTENDING COMPANIES INCLUDED: • 7 Days• Abbott Laboratories• AbbVie BioPharmaceuticals GmBH• ABC Dubai• Abu Dhabi National Insurance

Company• Aegis Capital• Aetna• Al Mariya Polyclinic• Al Noor Hospital• AlSharq Health Care Member of

Fujairah• National Group• American Hospital• Anglo Arabian Healthcare• Arya Insurance Brokerage

Company• AstraZeneca• Atlas Medical Technologies• Axa Insurance• Bait Al Batterjee Holding Company• Bayer Healthcare• Bennett Jones• BeUtiful You• BLI• Boehringer Ingelheim• Bristol-Myers Squibb• Burjeel Hospital• CAIN• ClinArt International• Clinart MENA• Dar Al Khaleej• DNA Health Corp• Dubai Eye 103.8• Dubai Health Authority• DuBiotech

• Economist Intelligence Unit• Edelman• Eli Lilly and Company• Emmahim Global Network Link• Falcon and Associates• GE Healthcare• Grayling• GSK• Gulf News• Health Authority of Abu Dhabi• Health Beyond Borders• Healthcare Industry Service Center• Hoffmann-La Roche Ltd• ICME International• Janssen Gulf• Johns Hopkins Aramco Healthcare• Joint Commission International• Julphar• KARL STORZ - ENDOSKOPE East

Mediterranean Gulf• King Hussein Cancer Foundation• King Saud bin Abdulaziz University• Kleos Healthcare Corporation• Kuwait News Agency (KUNA)• Leo Pharma• Les Laboratoires Servier - Gulf

Region• Lux Actuaries and Consultants• Mafraq Hospital- SEHA• Manchester Clinic Jumeriah• MD Lifeline Hospital• MedDrop GmbH• Mediclinic City Hospital Dubai• MEED• Menasa and Partners• Merck Sharp & Dohme

• Middle East Health Magazine• Moorland Gray Executive Search• Mundipharma• NGC Medical• NMC Healthcare• Novartis• Now Health International• Oracle Middle East and North

Africa• Pfizer• Pharmax Pharmaceuticals FZ• Philips• PhRMAG• Prime Minister’s Office, UAE• Quanteus• RAK Hospital• Sanofi• Saudi Aramco• Shane Phillips Consultants• Sheikh Khalifa Medical City• Siegel+Gale• Spengler Fox• Supreme Council of Health• Taha Actuaries & Consultants• Takeda• Tawam Hospital• TECOM Investments• The Gulf Today• The National• Thomson Reuters• U N CARGO & LOGISTIC• Vision Executive Search• vps healthcare

DELEGATE DETAILS

First Name (Dr/Mr/Mrs/Ms) Surname

Job Title Industry Sector

Company

Address

Town/city Postcode Country

Tel Fax Email

HOW TO REGISTER

ONLINE www.hcmena.economist.com

EMAIL emeaevents@economist.com

CALL US +44 (0) 20 7576 8118

FAX +44 (0) 20 7576 8472

POST The Economist Events, Customer Service EMEA, 20 Cabot Square, Canary Wharf, London E14 4QW, UK

DATA PROTECTION

The Economist Events is part of The Economist Group. Occasionally, the companies in The Economist Group would like to contact you about new features, events, news, special offers and for market research purposes.

Tick this box if you’d like to hear from us by e-mailWe’ll assume that we may contact you unless you tick these boxes:

No contact from us by post No contact from us by telephone

No contact from other selected companies about their products and services by post

The Economist Group is a global organisation and operates a strict privacy policy around the world. To read more about us and our privacy policy please go to www.economistgroup.com/privacy

TERMS AND CONDITIONS

Your delegate fee should be paid in full prior to attendance. If payment has not been received you will not be permitted to enter the event. Cancellations: Should you not be able to attend the event, substitutions can be made at no extra charge up until the event. If a suitable replacement cannot be found, then an administration fee of 20% will be incurred for cancellations received more than 21 days prior to an event. When a cancellation is made less than 21 days prior to an event, the registered delegate is liable for full payment of the fee. Economist Events reserve the right to change the programme if necessary.

Discounts are available for groups of 3 or more delegates.

Please email the team on emeaevents@economist.com or call +44 (0) 207 576 8118 for further details

CONFIRMATION

I confirm that I have read and accepted The Economist Events’ terms and

conditions policy and I am authorised to sign this document on behalf of the

above company.

Signature: Date:

Payment methods (delegates fee(s) strictly payable in advance)

Credit Card (tick as appropriate): Amex Visa Mastercard Name as it appears on card: Card No. Expiry date: / 3/4 digital security number:

Bank transfer Payable to Barclays Bank Plc, please quote ref: EM1342 and send a copy of the instructions together with your registration form. Account Name: The Economist Intelligence Unit. Account Number:54609155, Sort Code: 20-67-59. IBAN: GB09BARC20675954609155 Swift address: BARCGB22

We require an invoice to raise payment (Bookings with requests for bank tranfsers and invoices should be received before September 12th 2015.) Please complete below if the billing contact is not the registered delegate.

Billing contact: PO number (if required):

Billing address (if different from the Organisation address):

HEALTH CARE MIDDLE EAST AND NORTH AFRICAOctober 13th 2015 - Madinat Jumeirah, Mina A’Salam Hotel, Dubai, UAE

DELEGATE FEES (PER PERSON)

Category Standard Rate Quantity Total

Pharmaceutical & Biotech Companies $900.00

Health Care Providers $675.00

Subscribers to The Economist $720.00

Gov/NGOs/public sector $540.00

Total

WEB